HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.

AuthorsMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, Bei H Morrison, Zhuo Tang, Rhonda K Oates, Alex Almasan, Joseph A DiDonato, Ernest C Borden, Daniel J Lindner
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 294 Issue 48 Pg. 18518 (11 29 2019) ISSN: 1083-351X [Electronic] United States
PMID31784479 (Publication Type: Journal Article, Retraction of Publication)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: